Identification of Biomarkers of Mastitis

Status Recruiting

Clinical Trial Summary

Breastfeeding is the optimal feeding for infants. WHO currently promotes breastfeeding and recommends it to be exclusive until the baby is 6 months old. Breastfeeding has a positive impact on both the mother's and the infant's health and is directly associated with the decrease in diseases such as cancer, diabetes, cardiovascular disease, and inflammatory and infectious diseases. Currently, in Spain, only 39% of infants at 6 months are breastfed. The factors that influence the abandonment of breastfeeding are returning to work, the sensation of hypogalactia, problems to breastfeed, and breast complications, like mastitis, being the pain its main cause. Recent studies have associated pain while breastfeeding with mammary gland inflammation (mastitis) caused by dysbiosis. In order to increase breastfeeding rates, it is necessary to find factors related to the progression of mastitis in breastfeeding women. In this context, the discovery of predictive biomarkers based on metabolic markers is key to act before or at the beginning of the progression of mastitis and thus reduce the rates of abandonment of breastfeeding due to pain. The present project aims to identify and validate metabolic biomarkers capable of predicting mastitis. For this purpose, a prospective observational case-control hypothesis-free study will be carried out in order to identify and validate biomarkers of mastitis in breastfeeding women. The study will be performed in two phases: the discovery of the possible biomarkers and the validation of the biomarkers. Breast milk will be collected at the beginning of the study and when women present symptoms compatible with mastitis. The presence or not of mastitis will be confirmed with a milk culture. Milk samples will be analyzed using non-targeted metabolomics approach. Using multivariate statistical models, the potential metabolites capable of discriminating the presence of mastitis in maternal milk will be identified. Later, these potential markers will be validated in independent samples.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05021042
Study type	Observational
Source	LactApp Women's Health
Contact
Status	Recruiting
Phase
Start date	May 1, 2021
Completion date	April 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04487418` - Evaluation of the Effects of High-level Laser and Electro-cautery in Lingual Frenotomy Surgeries in Infants	N/A
Completed	`NCT03334266` - Preventing Early Childhood Obesity, Part 2: Family Spirit Nurture, Prenatal - 18 Months	N/A
Enrolling by invitation	`NCT02687685` - Clinical Trial of Immediate Skin to Skin Contact at Birth Early vs. Immediate (CPPITLH)	N/A
Completed	`NCT02913638` - A Post Breastfeeding Follow-Up Study	N/A
Completed	`NCT03033459` - Prenatal Lactation-Focused Motivational Interviewing	N/A
Completed	`NCT02952950` - Is it Possible to Prolong the Duration of Breastfeeding in Premature Infants? a Prospectivt Study	N/A
Not yet recruiting	`NCT05846828` - Cognitive Functions in Breastfed Preschool Children
Completed	`NCT05629403` - Exclusive Breastfeeding Improves Puerperal Glucose Metabolism in Pregnant Women With Gestational Diabetes Mellitus and Links to Lipids Composition
Completed	`NCT05944471` - The Effect of Telehealth on Feeding Exclusive Breastfeeding in the Perception of Insufficient Milk	N/A
Completed	`NCT04024865` - Domperidone and Risk of Serious Cardiac Events in Postpartum Women
Recruiting	`NCT05560750` - Lingual Frenulum in Newborn Infants (LINNE)	N/A
Completed	`NCT03232762` - Effects of Diet on Pregnancy Outcome and Child Obesity	N/A
Recruiting	`NCT02186613` - Telephone Support From Primary Care for Breastfeeding Mothers	N/A
Completed	`NCT01687634` - Home Visiting for Low Income, Pregnant Women	N/A
Completed	`NCT01459991` - The Mediterranean Diet and Lactation Study: A Diet Study in Lactating Women	N/A
Completed	`NCT03574766` - Meditation for NICU Moms	N/A
Recruiting	`NCT03945474` - Osteopathic Manipulation in Breastfed Newborns	N/A
Recruiting	`NCT06107933` - Developmental Impacts of Microplastics Exposure in Early Life
Not yet recruiting	`NCT05059574` - Breast Crawling,Breastfeeding Success and Mothers' Attitudes to Feeding Their Babies	N/A
Completed	`NCT04578925` - Happy, Healthy, Loved: A Mobile-delivered Breastfeeding Self-efficacy Intervention for First Time Parents	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.